Cisplatin (CP)-induced neurotoxicity is one of the major clinical problems in CP-based chemoradiotherapy, leading to its discontinuation depending upon their severity. In the present investigation, the photosensitizing property of riboflavin (RF) has been used to ameliorate the CP-induced neurotoxicity. According to dosing plan, the healthy mice were given RF, CP, and their combinations under photoillumination with their controls without any light exposure. After the treatment, antioxidant enzymes, cellular reductants, glutathione-S-transferase, brain markers, and oxidation products were assessed besides histopathology in their brain samples. These parameters revealed that RF ameliorates CP-induced neurotoxicity in a dose-dependent manner under photoillumination. Hence, inclusion of RF in CP-based chemoradiotherapy can be an effective strategy to counter CP-induced neurotoxicity.
Get full access to this article
View all access options for this article.
References
1.
TarladacalisirYT, KanterM, UygunM. Protective effect of vitamin C on cisplatin-induced renal damage: A light and electronic microscopic study. Ren Fail, 2008; 30:1.
2.
Mc DonaldES, RandonKR, KnightA, WindebankAJ. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: A potential mechanism of neurotoxicity. Neurobiol Dis, 2005; 18:305.
SiddikZH. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene, 2003; 22:7265.
5.
TaLE, EspesetL, PodratzJ, WindebankAJ. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology, 2006; 27:992.
6.
MinamiT, OkazakiJ, KawabataAet al.Lipopolysaccharide-induced platinum accumulation in the cerebral cortex after cisplatin administration in mice: Involvement of free radicals. Environ Toxicol Pharmacol, 1996; 2:321.
7.
ChirinoYI, TrujilloJ, Sanchez-GonzalezDJet al.Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett, 2008; 176:48.
8.
KumariMV, YonedaT, HiramatsuM. Scavenging activity of beta catechin on reactive oxygen species generated by photosensitization of riboflavin. Biochem Mol Biol Int, 1996; 38:1163.
9.
PerumalSS, ShathiP, SachdanandamP. Augmented efficiency of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin; niacin and CoQ 10: Effects on lipid peroxidation and antioxidants in mitochondria. Chem Biol Interact, 2005; 152:49.
10.
MuñozMA, PachecoA, BeckerMIet al.Different cell death mechanisms are induced by a hydrophobic flavin in human tumor cells after visible light irradiation. J Photochem Photobiol B: Biol, 2011; 103:57.
11.
De Souza QueirozKC, ZambuzziWF, Santos De SouzaACet al.A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumors. Cancer Lett, 2007; 258:126.
12.
RivlinRS. Riboflavin and cancer: A review. Cancer Res, 1973; 33:1977.
13.
HusainE, NaseemI. Riboflavin mediated cellular photoinhibition of cisplatin- induced oxidative DNA breakage in mice keratinocytes. Photodermatol Photoimmunol Photomed, 2008; 24:301.
14.
HassanI, ChibberS, NaseemI. Ameliorative effect of riboflavin on cisplatin induced nephrotoxicity and hepatotoxicity under photoillumination. Food Chem toxicol, 2010; 48:2052.
MarklundS, MarklundG. Involvement of superoxide anion radical in the auto-oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem, 1974; 47:469.
17.
AebiH. Catalase in vitro. Meth Enzymol, 1984; 105:121.
JollowDJ, MitchellJR, ZampaglioneN, GilletteJR. Bromobenzene induced liver necrosis: Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as hepatotoxic metabolite. Pharmacology, 1974; 11:151.
21.
SedalkJ, LindsayRH. Estimation of total, protein-bound and non-protein sulfydryl groups in tissues with Ellman's reagent. Anal Biochem, 1968; 25:192.
22.
ShonkCE, BoxerGE. Enzyme patterns in human tissues. I. Methods for the determination of glycolytic enzymes. Cancer Res, 1964; 24:709.
23.
KornbergA. Lactate dehydrogenase of muscle. Meth Enzymol, 1955; 1:441–443.
24.
HabigWH, PabstMJ, JokobyWB. Glutathione S- transferase: The first enzymatic step in mercapturic acid formation. J Biol Chem, 1974; 249:7130.
25.
ChirinoYI, Pedraza-ChaverriJ. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol, 2009; 61:223.
26.
MinamiT, IchiiM, OkazakiY. Detection of platinum in the brain of mice treated with cisplatin and subjected to short-term hypoxia. J Pharm Pharmacol, 1996; 48:505.
27.
MinamiT, OkazakiJ, KawabataAet al.Penetration of cisplatin into mouse brain by lipopolysaccharide. Toxicology, 1998; 130:107.
28.
OzyurtB, GulecM, OzyurtHet al.The effect of antioxidant caffeic acid phenethyl ester (CAPE) on some enzyme activities in cisplatin-induced neurotoxicity in rats. Eur J Gen Med, 2006; 3:167.
29.
CavelettiG, MinoiaC, SchieppatiM, TrediciG. Protective effects of glutathione on cisplatin neurotoxicity in rats. Int J Radiat Oncol Biol Phy, 1994; 29:771.
30.
DzagnidzeA, KatsaravaZ, MakhalovaJet al.Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J Neurosci, 2007; 27:9451.
31.
MoncadaS. Nitric oxide: Discovery and impact on clinical medicine. JRSM, 1999; 92:164.
32.
SonK, KimY-M. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthase for tumor cell killing. Cancer Res, 1995; 55:5524.
33.
OuryTD, HoYS, PiantadosiCA, CrapoJD. Extracellular superoxide dismutase, nitric oxide and central nervous system O2 toxicity. Proc Natl Acad Sci U S A, 1992; 89:9715.
34.
AndaT, YamashitaH, KhalidHet al.Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers. Neurol Res, 1997; 19:369.
35.
CavelettiG, TrediciG, MarmiroliPet al.Morphological study of sensory neurons and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol, 1992; 84:364.
36.
DonzelliE, CarfiM, MilosoMet al.Neurotoxicity of platinum compounds: Comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. J Neuro-Oncol, 2004; 67:65.
37.
MelliG, TaianaM, ComazziFet al.Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol, 2008; 214:276.
38.
De souzaACS, KodachL, GadelhaFRet al.A promising action of riboflavin as a mediator of leukemia cell death. Apoptosis, 2006; 11:1761.
39.
MiyashitaT, MasayoshiH, HanadaM, ReedJC. Identification of a p53- dependent negative response element in bcl-2 gene. Cancer Res, 1994; 54:3131.
40.
Sanchez-PerezI, MurguiaJR, PeronaR. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene, 1998; 16:533.
41.
GillJS, WindebankAJ. Cisplatin- induced apoptosis in rat dorsal ganglion neurons in associated with attempted entry into the cell cycle. J Clin Invest, 1998; 101:2842.
42.
LilgeL, PortnoyM, WilsonBC. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumor tissues. Br J Cancer, 2000; 83:1110.
43.
Chaves NetoAH, YanoCL, Paredes-GameroEJet al.Riboflavin and photoproducts in MC3T3-E1 differentiation. Toxicol In Vitro, 2010; 24:1911.
